| 英文别名： |
Dienogestrel;Dienogest;(17a)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;17a-Cyanomethyl-17-hydroxyestra-4, 9-dien-3-one;Dienogestril;Endometrion;STS 557;[14C]-Dienogest;[3H]-Dienogest;17a-CyanoMethyl-17b-hydroxyestra-4,9-dien-3-one;Dinagest;STS-557;17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;17-cyanomethyl-17-hydroxy-estra-4,9-dien-3-one;17α-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;Dienogestum;Natazia;Visanne;Dienogestum [Latin];46M3EV8HHE;DIENOGEST [VANDF];AKOS015840152;DIENOGEST [EP MONOGRAPH];DTXSID80891478;CS-1782;[(17?)-17-Hydroxy-3-oxoestra-4,9-dien-17-yl]acetonitrile;GTPL7654;2-((8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetonitrile;AKOS015896680;CHEMBL1201864;CHEBI:70708;DIENOGEST [USAN];19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17alpha)-;17-alpha-Cyanomethyl-17-beta-hydroxy-estra-4,9(10)-dien-3-one;Endometrion (TN);Dienogest (JAN/USAN/INN);STS557;DIENOGEST [MART.];Q139160;17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;19-NORPREGNA-4,9-DIENE-21-NITRILE, 17-HYDROXY-3-OXO-, (17.ALPHA.)-;Dienogest [INN];BRD-K50853363-001-02-3;BAY86-5258;17-alpha-Cyanomethyl-17-beta-hydroxyestra-4,9(10)-diene-3-one;SR-01000942230;UNII-46M3EV8HHE;ZK 37659;s1251;CCG-267594;Dienogest, EuropePharmacopoeia (EP) Reference Standard;65928-58-7;ZK-37659;BAY 86-5258;DIENOGEST [WHO-DD];17alpha-Cyanomethyl-17beta-hydroxyestra-4,9(10)-dien-3-one;AC-2166;DB09123;Dienogest, >=98% (HPLC);SH-T00660AA;M-18575;AZFLJNIPTRTECV-FUMNGEBKSA-N;DIENOGEST [ORANGE BOOK];M 18575;2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile;DIENOGEST [MI];Dienogest for system suitability, EuropePharmacopoeia (EP) Reference Standard;D03799;Dienogest [USAN:INN:BAN];Z2235801839;NCGC00346502-04;DIENOGEST [JAN];2-[(1R,3aS,3bS,11aS)-1-hydroxy-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]acetonitrile;Dienogest for system suitability;19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17-alpha)-;[(17beta)-17-hydroxy-3-oxoestra-4,9-dien-17-yl]acetonitrile;(17-hydroxy-3-oxoestra-4,9-dien-17beta-yl)acetonitrile;HY-B0084;17-Hydroxy-3-oxo-19-nor-17alpha-pregna-4,9-diene-21-nitrile;SCHEMBL37293;Dienogest; Dienogestril; Dinagest; STS 557; (17alpha)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; 17alpha-Cyanomethyl-17beta-hydroxyestra-4,9-dien-3-one;MJR-35;AB01566807_01;NS00000598;EN300-6477654;SR-01000942230-1;MFCD00868356;BCP22681;D5230 |
沪公网安备 
